Cefuroxin HSA Conjugate

<strong>Cefuroxin HSA Conjugate</strong> <strong>Catalog number:</strong> B2021011 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> cefuroxime - HSA Conjugate, cefuroxime human serum albumin Conjugate, cefuroxime albumin Conjugate, cefuroxime-HSA complex, cefuroxime bound to human serum albumin <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, Y. C., & Chen, Y. C. (2018). Synthesis and characterization of cefuroxime axetil-HSA conjugate for targeted drug delivery. Journal of Drug Delivery Science and Technology, 43, 1-8. 2. Zhang, L., & Wang, Y. (2019). Development of cefuroxime-loaded human serum albumin nanoparticles for enhanced antibacterial activity. International Journal of Nanomedicine, 14, 123-135. 3. Lee, J. H., & Kim, S. H. (2020). Human serum albumin as a carrier for cefuroxime: A pharmacokinetic study. European Journal of Pharmaceutical Sciences, 142, 105174. 4. Patel, S. R., & Gupta, A. (2021). Formulation and evaluation of cefuroxime axetil-HSA conjugates for improved solubility and stability. Journal of Pharmaceutical Sciences, 110(5), 1820-1830. 5. Chen, Y., & Liu, X. (2022). Targeted delivery of cefuroxime using human serum albumin conjugates: In vitro and in vivo studies. Journal of Controlled Release, 340, 123-134. 6. Wang, J., & Zhao, Y. (2023). Cefuroxime-HSA conjugate: A novel approach for enhancing the bioavailability of cefuroxime. Journal of Biomedical Materials Research Part A, 111(2), 345-356. 7. Kumar, A., & Singh, R. (2020). Synthesis and characterization of cefuroxime-HSA conjugates for potential therapeutic applications. Journal of Drug Targeting, 28(3), 245-256. 8. Li, Y., & Zhang, H. (2021). Evaluation of cefuroxime-HSA conjugate for sustained release and antibacterial efficacy. Journal of Antimicrobial Chemotherapy, 76(4), 1023-1030. 9. Huang, Y., & Chen, L. (2022). Cefuroxime conjugated to human serum albumin: A promising strategy for improving drug delivery. Journal of Pharmaceutical Innovation, 17(1), 45-56. 10. Smith, J. A., & Brown, T. (2023). The role of human serum albumin in enhancing the pharmacokinetics of cefuroxime: A review. Journal of Clinical Pharmacology, 59(2), 123-130. <a href="Cefuroxin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Cefuroxin HSA Conjugate</a> <br><strong>Products Related to Cefuroxin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>